Role of ERK signaling in pristimerin-induced apoptosis and autophagy: involvement of ROS-dependent mechanisms in Cutaneous T-cell lymphoma
This study investigates the role of ERK signaling in PS-induced apoptosis and autophagy. PS treatment activated MAP kinases in CTCL cells, with robust ERK activation contrasting with variable p38/JNK responses. Pharmacological ERK inhibition significantly reversed PS-mediated loss of viability, morphological and nuclear alterations, and apoptosis (PI/Annexin V). Mechanistically, ERK blockade suppressed PS-induced cleaved caspase-3, −8, −9, PARP, and γH2AX, confirming ERK drives proapoptotic cascades. PS also triggered autophagic flux, evidenced by increased LC3 and decreased Beclin1/p62, effects reversed by 3-methyladenine. ERK inhibition attenuated PS-induced MDC staining, indicating ERK-dependent autophagic cell death. Moreover, the ROS scavenger N-acetyl-L-cysteine inhibited both PS-induced ERK activation and apoptosis, positioning ROS upstream of ERK signaling. Altogether, these findings demonstrate that PS-mediates ERK-dependent proapoptotic and proautophagic signaling via ROS activity, suggesting ERK signaling as a key determinant of PS’s anticancer activity in CTCL.
Authors
- Shahab Uddin M.S. (ORCID: https://orcid.org/0000-0003-1886-6710)
- Maha Al-Tamimi
- Ummu Habeeba (ORCID: https://orcid.org/0009-0008-3142-8516)
- Fareed Ahmad (ORCID: https://orcid.org/0000-0003-2827-8744)
- Rasheeda Anver
- Kirti Sathyananda Prabhu
- Abdul Q. Khan
Institutions
- Hamad Medical Corporation (QA)
Publication Details
- Journal
- Leukemia & lymphoma/Leukemia and lymphoma
- Published
- 2026-11-17
- DOI
- https://doi.org/10.1080/10428194.2026.2760718
- Primary Topic
- Cutaneous lymphoproliferative disorders research
- Type
- article
- Field-Weighted Citation Impact
- 0.00